United States· US:0338-0519_7f10161b-9f00-3f03-e053-2991aa0adcd4
Intralipid
A medicinal product containing soybean oil, registered in United States by Baxter Healthcare Corporation.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- SOYBEAN OIL
- Manufacturer
- Baxter Healthcare Corporation
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1103380519041000 mL in 1 BAG (0338-0519-04)
- ndc110338-0519-04
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Soybean oil in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBalneum 84.75% bath oilSigma Pharmaceuticals Plc
- BelgiumDemoleum N5ENoridem Enterprises
- Japanダイズ油
- PolandIntralipid 10%Fresenius Kabi AB
- SwitzerlandBalmed Hermal, Medizinisches OelbadAlmirall AG
- SpainINTRALIPID 200 mg/ml EMULSION PARA PERFUSIONFresenius Kabi España, S.A.U.
- FranceINTRALIPIDE 20 %, émulsion pour perfusionFRESENIUS KABI FRANCE
- IcelandIntralipidFresenius Kabi AB
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Austria · Balneum
- Czechia · Balneum, Intralipid
- Germany · Balneum Hermal
- United Kingdom (Northern Ireland) · Balneum
- Iceland · Intralipid
- Luxembourg · Balneum Hermal
- Portugal · Banhóleum
- Slovakia · Balneum
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d3f302c8-5dab-40b3-a2e0-e1cdca4715a0 GET /v1/drugs/d3f302c8-5dab-40b3-a2e0-e1cdca4715a0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "20",
"substance": "SOYBEAN OIL",
"productndc": "0338-0519",
"dosage_form": "EMULSION",
"dea_schedule": null,
"strength_unit": "g/100mL",
"application_number": "NDA020248",
"marketing_category": "NDA"
}See everything about soybean oil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.